Correlation Between Neurocrine Biosciences and Hepion Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Neurocrine Biosciences and Hepion Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Neurocrine Biosciences and Hepion Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Neurocrine Biosciences and Hepion Pharmaceuticals, you can compare the effects of market volatilities on Neurocrine Biosciences and Hepion Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Neurocrine Biosciences with a short position of Hepion Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Neurocrine Biosciences and Hepion Pharmaceuticals.
Diversification Opportunities for Neurocrine Biosciences and Hepion Pharmaceuticals
-0.33 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Neurocrine and Hepion is -0.33. Overlapping area represents the amount of risk that can be diversified away by holding Neurocrine Biosciences and Hepion Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Hepion Pharmaceuticals and Neurocrine Biosciences is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Neurocrine Biosciences are associated (or correlated) with Hepion Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Hepion Pharmaceuticals has no effect on the direction of Neurocrine Biosciences i.e., Neurocrine Biosciences and Hepion Pharmaceuticals go up and down completely randomly.
Pair Corralation between Neurocrine Biosciences and Hepion Pharmaceuticals
Given the investment horizon of 90 days Neurocrine Biosciences is expected to generate 0.38 times more return on investment than Hepion Pharmaceuticals. However, Neurocrine Biosciences is 2.61 times less risky than Hepion Pharmaceuticals. It trades about 0.46 of its potential returns per unit of risk. Hepion Pharmaceuticals is currently generating about -0.28 per unit of risk. If you would invest 11,762 in Neurocrine Biosciences on September 19, 2024 and sell it today you would earn a total of 1,907 from holding Neurocrine Biosciences or generate 16.21% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Neurocrine Biosciences vs. Hepion Pharmaceuticals
Performance |
| Timeline |
| Neurocrine Biosciences |
| Hepion Pharmaceuticals |
Neurocrine Biosciences and Hepion Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Neurocrine Biosciences and Hepion Pharmaceuticals
The main advantage of trading using opposite Neurocrine Biosciences and Hepion Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Neurocrine Biosciences position performs unexpectedly, Hepion Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Hepion Pharmaceuticals will offset losses from the drop in Hepion Pharmaceuticals' long position.| Neurocrine Biosciences vs. Amphastar P | Neurocrine Biosciences vs. Collegium Pharmaceutical | Neurocrine Biosciences vs. Ironwood Pharmaceuticals | Neurocrine Biosciences vs. ANI Pharmaceuticals |
| Hepion Pharmaceuticals vs. Enveric Biosciences | Hepion Pharmaceuticals vs. Elevation Oncology | Hepion Pharmaceuticals vs. Ocean Biomedical | Hepion Pharmaceuticals vs. Zura Bio Limited |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the ETFs module to find actively traded Exchange Traded Funds (ETF) from around the world.
Other Complementary Tools
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume |